D
Silo Pharma, Inc. SILO
$0.63 -$0.011-1.72% NASDAQ
Recommendation
Prev Close
$0.641
Volume
215,568
Avg Vol (90D)
701,009
Market Cap
$4.62M
Dividend & Yield
--
52-Week Range
$0.4101 - $4.50
P/E (TTM)
--
EPS (TTM)
-$1.14
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
6/29/2025 - Market Exclusive
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to ...
6/25/2025 - GuruFocus
Silo Pharma to form JV with Hoth Therapeutics for obesity treatment
6/25/2025 - SeekingAlpha.com: All News
Silo Pharma to form JV with Hoth Therapeutics for obesity treatment
6/25/2025 - Seeking Alpha - Healthcare
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to ...
6/25/2025 - GuruFocus
Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a ...
6/25/2025 - GuruFocus
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to ...
6/25/2025 - GuruFocus
Silo Pharma enters into letter of intent to form 50:50 joint venture with Hoth
6/25/2025 - The Fly
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
6/25/2025 - Globe Newswire
Hoth and Silo form strategic joint venture to develop obesity treatment
6/25/2025 - TipRanks Financial Blog
Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.
6/25/2025 - PR Newswire
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
6/16/2025 - Market Exclusive
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
6/11/2025 - GuruFocus
SILO Pharma Secures USPTO Approval for Key Patent Enhancing SPC-15 Protection SILO Stock News
6/11/2025 - GuruFocus
Silo Pharma secures biomarker patent for SPC-15
6/11/2025 - The Fly
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
6/11/2025 - Globe Newswire
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
6/5/2025 - GuruFocus
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset SILO ...
6/5/2025 - GuruFocus
Silo Pharma (SILO) Allocates $1 Million for Bitcoin Investment SILO Stock News
6/5/2025 - GuruFocus
Silo Pharma board approves purchase of bitcoin as treasury reserve
6/5/2025 - The Fly
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
6/5/2025 - Globe Newswire
Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Up 181.7% in May
5/29/2025 - Ticker Report
Silo Pharma's (NASDAQ:SILO) Groundbreaking Therapies Could Change The Treatment Landscape For PTSD, Fibromyalgia, MS & Alzheimer's
5/27/2025 - Simply Wall St
Silo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drug
5/21/2025 - Seeking Alpha - Healthcare
Silo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drug
5/21/2025 - SeekingAlpha.com: All News
Income Statement
Total Revenue (TTM)
$72.00K
EBITDA (TTM)
-$3.91M
EBIT (TTM)
-$4.92M
Net Income (TTM)
-$4.62M
Balance Sheet
Total Assets (Q)
$5.90M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$1.89M
Book Value Per Share (Q)
$0.8944
Cash Flow
Cash from Operations (TTM)
-$4.64M
Cash from Investing (TTM)
$1.75M
Cash from Financing (TTM)
$3.36M
Net Change in Cash (TTM)
$468.60K
Filings
Filing Date
Friday, May 9, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
1.00
7-Day Total Return
6.35%
30-Day Total Return
21.18%
60-Day Total Return
-41.67%
90-Day Total Return
-58.00%
Year to Date Total Return
-33.68%
1-Year Total Return
-37.00%
2-Year Total Return
-69.27%
3-Year Total Return
-90.98%
5-Year Total Return
-97.20%
52-week Low
May 22, 2025 - $0.4101
52-week High
Jul 18, 2024 - $4.50
Valuation
Market Cap
$4.62M - Nano Cap
Enterprise Value
-$831.24K
Price/Sales (TTM)
40.06
Price/Book (Q)
0.72
Dividends and Shares
Shares Outstanding
4.48M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
silopharma.com
Phone Number
718 400 9031
Address
677 North Washington Boulevard
Sarasota, FL 34236
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder... more
NASDAQ 06/30/2025 4:00PM Eastern Quotes delayed